Items without sitelinks
Jump to navigation
Jump to search
Showing below up to 50 results in range #951 to #1,000.
- secondary sex characteristic (Q21570)
- sex steroid (Q21569)
- Somatotropin/prolactin (Q21568)
- growth hormone (Q21567)
- Nasdaq Copenhagen A/S (Q21566)
- connectedness (Q21565)
- electoral unit (Q21564)
- Greenland (Q21563)
- type of business entity in Denmark (Q21562)
- aktieselskab (Q21561)
- Federal Government of the United States (Q21558)
- executive branch of the U.S. government (Q21557)
- United States federal executive department (Q21556)
- ministry of health (Q21555)
- United States Department of Health and Human Services (Q21554)
- quango (Q21553)
- council (Q21552)
- commission (Q21551)
- government commission (Q21550)
- regulatory agency (Q21549)
- supervisory authority (Q21548)
- food safety organization (Q21547)
- Food and Drug Administration (Q21546)
- recombinant protein (Q21544)
- INS (Q21542)
- protein modification (Q21541)
- disulfide crosslinked residues (Q21540)
- insulin A chain (Q21539)
- Relaxin (Q21538)
- insulin-like growth factor I (Q21537)
- Insulin-like growth factor II E-peptide, C-terminal (Q21536)
- Insulin-like growth factor (Q21535)
- Insulin-like growth factor II (Q21534)
- Insulin-like peptide 6 (Q21533)
- growth factor (Q21532)
- Bombyxin (Q21531)
- Insulin-related peptide (Q21530)
- Insulin, conserved site (Q21529)
- Insulin, conserved site, protein family (Q21528)
- Nematode insulin-related peptide, beta type (Q21527)
- Insulin-like (Q21526)
- Insulin-like domain, protein family (Q21525)
- Insulin-like superfamily (Q21524)
- Insulin family (Q21523)
- Insulin/IGF/Relaxin family (Q21522)
- preproinsulin (Q21521)
- insulin B chain (Q21520)
- maturity-onset diabetes of the young (Q21519)
- maturity-onset diabetes of the young type 2 (Q21518)
- insulin metabolic process (Q21517)